Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Immunologic Research
|
March 10, 2022
Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis
Cornelia Lackner, Michael Karbiener, Lukas Faltner, et al.
Clinical and Vaccine Immunology : CVI
|
March 2, 2012
Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations
Philip O Rabel, Christina B Planitzer, Maria R Farcet, et al.
The Journal of Infectious Diseases
|
September 17, 2020
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
Julia Schwaiger, Michael Karbiener, Claudia Aberham, et al.
The Journal of Infectious Diseases
|
March 16, 2021
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic
Maria R Farcet, Michael Karbiener, Julia Schwaiger, et al.
The Journal of Allergy and Clinical Immunology
|
December 8, 2009
Hepatitis A virus antibodies in immunoglobulin preparations
Maria R Farcet, Christina B Planitzer, Oliver Stein, et al.
Transfusion
|
November 20, 2023
Human Circovirus is not detected in plasma pools for fractionation
Philippe Pérot, Nicolas Da Rocha, Maria R Farcet, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
July 29, 2023
On-column virus inactivation by solvent/detergent treatment for a recombinant biological product
Daniel Polasek, Andreas Flicker, Christian Fiedler, et al.
Transplantation
|
June 11, 2011
Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations
Christina B Planitzer, Marcus D Saemann, Hartwig Gajek, et al.
Transfusion
|
October 3, 2024
Parvovirus B19 rebound outbreak 2024 and implications for blood- and plasma-product safety
Maria R Farcet, Michael Karbiener, Claudia Aberham, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 6, 2020
SARS-CoV-2 and the safety margins of cell-based biological medicinal products
Jens Modrof, Astrid Kerschbaum, Maria R Farcet, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Immunologic Research
|
March 10, 2022
Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis
Cornelia Lackner, Michael Karbiener, Lukas Faltner, et al.
Clinical and Vaccine Immunology : CVI
|
March 2, 2012
Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations
Philip O Rabel, Christina B Planitzer, Maria R Farcet, et al.
The Journal of Infectious Diseases
|
September 17, 2020
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
Julia Schwaiger, Michael Karbiener, Claudia Aberham, et al.
The Journal of Infectious Diseases
|
March 16, 2021
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic
Maria R Farcet, Michael Karbiener, Julia Schwaiger, et al.
The Journal of Allergy and Clinical Immunology
|
December 8, 2009
Hepatitis A virus antibodies in immunoglobulin preparations
Maria R Farcet, Christina B Planitzer, Oliver Stein, et al.
Transfusion
|
November 20, 2023
Human Circovirus is not detected in plasma pools for fractionation
Philippe Pérot, Nicolas Da Rocha, Maria R Farcet, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
July 29, 2023
On-column virus inactivation by solvent/detergent treatment for a recombinant biological product
Daniel Polasek, Andreas Flicker, Christian Fiedler, et al.
Transplantation
|
June 11, 2011
Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations
Christina B Planitzer, Marcus D Saemann, Hartwig Gajek, et al.
Transfusion
|
October 3, 2024
Parvovirus B19 rebound outbreak 2024 and implications for blood- and plasma-product safety
Maria R Farcet, Michael Karbiener, Claudia Aberham, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 6, 2020
SARS-CoV-2 and the safety margins of cell-based biological medicinal products
Jens Modrof, Astrid Kerschbaum, Maria R Farcet, et al.
Page
of 4